ES270748A1 - Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas - Google Patents
Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicasInfo
- Publication number
- ES270748A1 ES270748A1 ES270748A ES270748A ES270748A1 ES 270748 A1 ES270748 A1 ES 270748A1 ES 270748 A ES270748 A ES 270748A ES 270748 A ES270748 A ES 270748A ES 270748 A1 ES270748 A1 ES 270748A1
- Authority
- ES
- Spain
- Prior art keywords
- substituted
- diazines
- dihydrobenzo
- dioxo
- translation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003839 salts Chemical class 0.000 title abstract 3
- 231100000252 nontoxic Toxicity 0.000 title abstract 2
- 230000003000 nontoxic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 abstract 1
- ULIKDJVNUXNQHS-UHFFFAOYSA-N 2-Propene-1-thiol Chemical compound SCC=C ULIKDJVNUXNQHS-UHFFFAOYSA-N 0.000 abstract 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 abstract 1
- 125000002777 acetyl group Chemical class [H]C([H])([H])C(*)=O 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- -1 alkali metal salt Chemical class 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000002490 anilino group Chemical class [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002373 hemiacetals Chemical class 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- PVWOIHVRPOBWPI-UHFFFAOYSA-N n-propyl iodide Chemical compound CCCI PVWOIHVRPOBWPI-UHFFFAOYSA-N 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
- C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
- C07D285/30—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with hydrocarbon radicals, substituted by hetero atoms, attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04D—NON-POSITIVE-DISPLACEMENT PUMPS
- F04D29/00—Details, component parts, or accessories
- F04D29/08—Sealings
- F04D29/10—Shaft sealings
- F04D29/12—Shaft sealings using sealing-rings
- F04D29/126—Shaft sealings using sealing-rings especially adapted for liquid pumps
- F04D29/128—Shaft sealings using sealing-rings especially adapted for liquid pumps with special means for adducting cooling or sealing fluid
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Mechanical Engineering (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Structures Of Non-Positive Displacement Pumps (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58632A US3102882A (en) | 1960-09-27 | 1960-09-27 | Derivatives of 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide |
| GB991/61A GB902658A (en) | 1960-09-27 | 1961-01-10 | 6-substituted (or unsubstituted) 2-alkyl-3-allylthiomethyl-7-sulphamyl-3,4-dihydrobenzothiadiazine dioxides and process for preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES270748A1 true ES270748A1 (es) | 1961-12-16 |
Family
ID=26236340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES270748A Expired ES270748A1 (es) | 1960-09-27 | 1961-09-26 | Un procedimiento para preparar 3-alil-tiometil-7-sulfamil-3,4-dihidrobenzo-1,1-dioxo-1-tia-2,4-diazinas 6-sustituídas y sus sales no tóxicas |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US3102882A (enExample) |
| BE (1) | BE606063A (enExample) |
| DE (2) | DE1445121A1 (enExample) |
| ES (1) | ES270748A1 (enExample) |
| FR (1) | FR1426M (enExample) |
| GB (2) | GB902658A (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3265573A (en) * | 1962-07-27 | 1966-08-09 | Squibb & Sons Inc | Benzothiadiazinesulfonamide-1, 1-dioxide composition |
| US3251837A (en) * | 1962-09-14 | 1966-05-17 | Pfizer & Co C | Derivatives of 1, 2, 4-benzothiadiazine-1, 1-dioxides |
| US4338435A (en) * | 1981-06-01 | 1982-07-06 | E. R. Squibb & Sons, Inc. | Benzothiadiazines having diuretic activity |
| US6982251B2 (en) | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
| KR20070120617A (ko) | 2001-01-26 | 2007-12-24 | 쉐링 코포레이션 | 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물 |
| US7071181B2 (en) | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
| IL156445A0 (en) | 2001-01-26 | 2004-01-04 | Schering Corp | Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| US7053080B2 (en) | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
| US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
| EP1429756B1 (en) | 2001-09-21 | 2006-11-22 | Schering Corporation | Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors |
| EA200500234A1 (ru) | 2002-08-19 | 2005-08-25 | Пфайзер Продактс Инк. | Комбинированная терапия гиперпролиферативных болезней |
| CA2504916A1 (en) | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorptions inhibitors for the treatment of autoimmune disorders |
| DE602004018617D1 (de) | 2003-03-07 | 2009-02-05 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
| WO2004081002A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| US7459442B2 (en) | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
| WO2004081004A1 (en) | 2003-03-07 | 2004-09-23 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| WO2008151257A2 (en) | 2007-06-04 | 2008-12-11 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2627848T3 (es) | 2008-06-04 | 2017-07-31 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| PL3004138T3 (pl) | 2013-06-05 | 2024-07-29 | Bausch Health Ireland Limited | Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
-
0
- DE DENDAT1302648D patent/DE1302648B/de active Pending
-
1960
- 1960-09-27 US US58632A patent/US3102882A/en not_active Expired - Lifetime
-
1961
- 1961-01-10 GB GB991/61A patent/GB902658A/en not_active Expired
- 1961-05-16 GB GB17822/61A patent/GB905137A/en not_active Expired
- 1961-06-24 DE DE19611445121 patent/DE1445121A1/de active Pending
- 1961-07-12 BE BE606063A patent/BE606063A/fr unknown
- 1961-07-12 FR FR867816A patent/FR1426M/fr active Active
- 1961-09-26 ES ES270748A patent/ES270748A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US3102882A (en) | 1963-09-03 |
| GB905137A (en) | 1962-09-05 |
| GB902658A (en) | 1962-08-09 |
| DE1445121A1 (de) | 1968-11-28 |
| FR1426M (fr) | 1962-08-06 |
| BE606063A (fr) | 1962-01-12 |
| DE1302648B (enExample) |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES385635A1 (es) | Procedimiento para la preparacion de n-alil-2-arilamino - imidazolinos-(2) sustituidas. | |
| SE7602144L (sv) | Kvaternera imidazoliumforeningar | |
| ES246512A1 (es) | PROCEDIMIENTO PARA LA PREPARACION DE NUEVOS DERIVADOS DEL áCIDO AMINOBENZOICO | |
| ES440760A1 (es) | Procedimiento para preparar derivados de quinoxalina y qui- nazolina. | |
| ES457993A1 (es) | Un procedimiento para la preparacion de una isotiazolopiri- dina. | |
| ES391633A1 (es) | Un procedimiento para la preparacion de una 2,2-diaril-4- piperidinobutiramida. | |
| YU91483A (en) | Process for obtaining new thiomethylpyridine derivatives | |
| ES267590A1 (es) | Un procedimiento para preparar compuestos quimicos | |
| ES385634A1 (es) | Procedimiento para la preparacion de n - cicloalcohil - a- ril - amino - imidazolinas-(2) sustituidas. | |
| US2790806A (en) | Heterocyclic compounds and their preparation | |
| ES315051A1 (es) | Metodo para la preparaciën de derivados de isoflavonas naturales | |
| ES286931A1 (es) | Procedimiento de preparación de nuevos derivados del ácido salicílico | |
| ES450109A1 (es) | Mejoras introducidas en un procedimiento de obtencion de de-rivados de fenotiazina. | |
| ES274329A1 (es) | Procedimiento para la preparacion de nuevos compuestos de 1,5-benzodioxepano | |
| ES441257A1 (es) | Procedimiento para preparar aminocicloles. | |
| Calingaert et al. | The Intermetallic Compound Mg4Na4Pb3 | |
| ES307273A1 (es) | Procedimiento para la obtencion de compuestos heterociclicos | |
| ES274332A1 (es) | Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano | |
| ES396415A1 (es) | Un procedimiento para la preparacion de poliarilimidazolas. | |
| GB1076966A (en) | 2-aminoindane derivatives | |
| GR23094B (el) | Μεθοδος παρασκευης χημικου προιοντος. | |
| ES350159A1 (es) | Procedimiento para la preparacion de derivados de benzodia-cepina. | |
| ES282825A1 (es) | Procedimiento para la obtención de nuevos derivados de piperidina | |
| ES338181A1 (es) | Un procedimiento para la preparacion de compuestos dotados de propiedades antibacterianas. | |
| ES240642A1 (es) | PROCEDIMIENTO PARA OBTENER NUEVOS COMPUESTOS ORGáNICOS |